Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 8
2022 13
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
Regev-Yochay G, Gonen T, Gilboa M, Mandelboim M, Indenbaum V, Amit S, Meltzer L, Asraf K, Cohen C, Fluss R, Biber A, Nemet I, Kliker L, Joseph G, Doolman R, Mendelson E, Freedman LS, Harats D, Kreiss Y, Lustig Y. Regev-Yochay G, et al. Among authors: nemet i. N Engl J Med. 2022 Apr 7;386(14):1377-1380. doi: 10.1056/NEJMc2202542. Epub 2022 Mar 16. N Engl J Med. 2022. PMID: 35297591 Free PMC article. No abstract available.
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, Kreiss Y, Alroy-Preis S, Regev-Yochay G, Mendelson E, Mandelboim M. Nemet I, et al. N Engl J Med. 2022 Feb 3;386(5):492-494. doi: 10.1056/NEJMc2119358. Epub 2021 Dec 29. N Engl J Med. 2022. PMID: 34965337 Free PMC article. No abstract available.
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants.
Makdasi E, Zvi A, Alcalay R, Noy-Porat T, Peretz E, Mechaly A, Levy Y, Epstein E, Chitlaru T, Tennenhouse A, Aftalion M, Gur D, Paran N, Tamir H, Zimhony O, Weiss S, Mandelboim M, Mendelson E, Zuckerman N, Nemet I, Kliker L, Yitzhaki S, Shapira SC, Israely T, Fleishman SJ, Mazor O, Rosenfeld R. Makdasi E, et al. Among authors: nemet i. Cell Rep. 2021 Sep 7;36(10):109679. doi: 10.1016/j.celrep.2021.109679. Epub 2021 Aug 21. Cell Rep. 2021. PMID: 34464610 Free PMC article.
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2.
Israeli M, Finkel Y, Yahalom-Ronen Y, Paran N, Chitlaru T, Israeli O, Cohen-Gihon I, Aftalion M, Falach R, Rotem S, Elia U, Nemet I, Kliker L, Mandelboim M, Beth-Din A, Israely T, Cohen O, Stern-Ginossar N, Bercovich-Kinori A. Israeli M, et al. Among authors: nemet i. Nat Commun. 2022 Apr 25;13(1):2237. doi: 10.1038/s41467-022-29896-z. Nat Commun. 2022. PMID: 35469023 Free PMC article.
Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
Kriger O, Gefen-Halevi S, Leshem E, Smollan G, Belausov N, Egbarye A, Khashab R, Odeh M, Saffia A, Barak Y, Hussein OA, Hamias R, Aharon Y, Alfandari J, Nemet I, Kliker L, Sherbany H, Mandelboim M, Amit S. Kriger O, et al. Among authors: nemet i. Int J Infect Dis. 2022 Mar;116:226-229. doi: 10.1016/j.ijid.2022.01.018. Epub 2022 Jan 14. Int J Infect Dis. 2022. PMID: 35038602 Free PMC article.
24 results